Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681601 · ClinicalTrials.gov registry record · NA
Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02681601: Clinical Trial NA study, sponsored by Jonsson Comprehensive Cancer Center.
NCT02681601 is a NA study that was terminated before completion, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02681601, a NA study, was terminated before completion, sponsored by Jonsson Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
There are few well-designed studies evaluating the effect of nutrition support in patients with cancer cachexia. The aim of this study is to examine the effect of dietary prescription with and without nutrition supplementation in patients with unresectable pancreatic cancer on body weight, body composition, total calorie intake, quality of life and blood inflammatory markers.
Primary Outcome
Weight in Kilograms
Interventions
- OTHER Diet Only
- DIETARY_SUPPLEMENT Nutrawell Powder
- DIETARY_SUPPLEMENT OmegaRich fish oil supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-07-19 |
| Est. Completion | 2021-10-01 |
| Phase | NA |
Why NCT02681601 stopped before completion
NCT02681601 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Diet Only is the first listed.
NCT02681601 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02681601 about?
NCT02681601 is a clinical study titled "Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer". There are few well-designed studies evaluating the effect of nutrition support in patients with cancer cachexia. The aim of this study is to examine the effect of dietary prescription with and without nutrition supplementation in patients with unresectable pancreatic cancer on body weight, body comp...
What is the current status of trial NCT02681601?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2016-07-19. Estimated completion is 2021-10-01.
What interventions are being tested in trial NCT02681601?
The interventions under investigation include: Diet Only (OTHER), Nutrawell Powder (DIETARY_SUPPLEMENT), OmegaRich fish oil supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02681601?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02681601's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI